Abstract
The treatment of high blood pressure (BP) after myocardial infarction is extremely important to decrease reinfarction and mortality. BP should be controlled more strictly in this high-risk hypertensive population. Recently, many clinical trials have demonstrated the benefits of lifestyle modification and antihypertensive agents, particularly β-blockers and angiotensin- converting-enzyme inhibitors for the treatment of acute myocardial infarction. Treatment with these agents that modify BP may benefit even normotensive patients after a myocardial infarction, although the benefit is greater in hypertensives.
| Original language | English |
|---|---|
| Pages (from-to) | 1-21 |
| Number of pages | 21 |
| Journal | Medical Clinics of North America |
| Volume | 84 |
| Issue number | 1 |
| DOIs | |
| State | Published - 2000 |
| Externally published | Yes |